Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-Up. Article

Overview

authors

Woyach, Jennifer A

Rosenberg, Tanya S

Boyer, Michelle

Furman, Richard R
Wierda, William
Gotlib, Jason
Schuster, Stephen J
Chyla, Brenda
Davids, Matthew S

publication date

April 8, 2026

published in

American journal of hematology Journal

Identity

Scopus Document Identifier

105035194727

Digital Object Identifier (DOI)

10.1002/ajh.70275

PubMed ID

41952045